This CEO sells low-cost drugs, and he says Big Pharma might not be the true adversary

Cost Plus Drugs CEO Alex Oshmyansky TK on the latest episode of the “Rapid Response” podcast.

For many Americans, pharmaceutical drugs are too expensive—and thanks to a system of complex and tedious bureaucracy, any effort for meaningful reform has been futile. Cost Plus Drugs wants to change that. With the help of co-founder Mark Cuban, CEO Alex Oshmyansky is radically re-engineering the pharma marketplace and dramatically cutting the price for many prescription drugs. Oshmyansky shares why Big Pharma might not be the true adversary, how Y Combinator got his company off the ground, and his hopes for helping to change healthcare for the masses.